
Freya Meds Review
Best for: patients wanting dietitian-supported compounded GLP-1 programs
Freya Meds is a GLP-1 specialist offering compounded semaglutide ($250–$297/mo) and compounded tirzepatide ($332–$390/mo). Includes unlimited doctor consultations, monthly group calls, and dietitian consultation. Claims 450,000+ enrolled.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Freya Meds is a solid telehealth option with balanced features and pricing.
Freya Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $250/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Freya Meds
Each dimension is scored algorithmically from Freya Meds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.1/10At $250/mo, Freya Meds runs about 47% above the $170 median for GLP-1 providers.
Effectiveness25%
8.0/10Freya Meds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience — consult included in the price; 5 platform features disclosed.
Trust & Safety15%
7.9/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).
Accessibility10%
6.0/10Freya Meds's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.7/10Coaching/nutrition support offered, community/group support.
How we verified this Freya Meds review
Last checked 2026-06-06- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Freya Meds offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Freya Meds's current pricing and active discounts before you decide.
What we like
- GLP-1 specialist — not a multi-category telehealth
- Price includes unlimited doctor consultations, monthly group calls, and a dietitian consultation
- Both semaglutide and tirzepatide available
- Multi-month discount on quarterly billing
- Claims 450,000+ enrolled
Watch-outs
- No visible LegitScript or PCAB accreditation
- Above-average pricing ($250–$390/mo)
- Compounded only — no brand-name options
- Now serves 49 U.S. states (one state excluded; specific exclusion not named)
Freya Meds: a focused GLP-1 program built around billing-cycle pricing
Freya Meds is one of the rare telehealth brands that does only one thing: prescribe and ship compounded GLP-1 medication for weight loss. There's no men's-health upsell, no skincare counter, no anxiety line. It's a single-lane operation offering compounded semaglutide and compounded tirzepatide, and the company says it has enrolled more than 450,000 patients across 49 U.S. states. For someone who wants a dedicated GLP-1 service with a dietitian touchpoint built in, that focus is the main reason to look here. The catch is that you pay a premium for it, and the headline number you see depends entirely on how long a commitment you're willing to make upfront.
How the pricing actually works — you're buying a billing plan, not a dose
This is the part to understand before anything else. Freya doesn't price by milligram; it prices by how far ahead you pay. Compounded semaglutide runs $250 a month if you're billed quarterly, and a bit more if you pay month to month. Compounded tirzepatide sits noticeably higher, with the same quarterly-versus-monthly split. In other words, the same medication and the same dose can cost you two different monthly figures purely based on your plan length. The longer you lock in, the lower the per-month rate drops — Freya advertises plan floors well below its standard rate for people who commit to six- or twelve-month terms.
Be honest with yourself about that trade-off. Quarterly and yearly plans mean you're paying for months of medication before you know whether the drug agrees with you or whether you'll tolerate the dose escalation. GLP-1s commonly cause nausea early on, and not everyone sticks with them. The cheapest Freya rates are real, but they reward commitment, not caution.
Where it lands against the rest of the market
Freya is not a budget option. Even its lowest standard monthly rate of $250 sits above the $170 category median for compounded GLP-1 programs, and the tirzepatide tier climbs higher still. You are paying a premium relative to the cheapest compounders out there. What you're meant to get for that premium is the bundled support — see below — rather than the lowest possible price on the drug itself.
What the price includes
- Your personalized GLP-1 prescription (the medication itself)
- Free shipping straight to your door
- Unlimited doctor and care-team consultations
- Monthly live group calls with Q&A
- One consultation with Freya's dietitian
That bundle is genuinely more generous than a bare medication-only subscription. Unlimited clinician access matters when you're titrating up and want to ask about side effects without paying per message. Just read the fine print on the softer perks: the group calls are monthly group sessions, not private coaching, and the dietitian piece is a single consultation rather than ongoing nutrition support. If you were hoping for a one-on-one coach checking in every week, this isn't that.
The medications and how they reach you
Both offerings are compounded — meaning made-to-order by a compounding pharmacy, not the FDA-approved brand-name pens. Semaglutide is dosed on the familiar weekly ramp from a low starting dose up toward the higher maintenance range, and tirzepatide follows its own weekly escalation. There are no brand-name Wegovy, Ozempic, Zepbound, or Mounjaro options here, and no oral pills — injectable compounded vials only. If brand-name medication or insurance billing is what you want, Freya isn't built for that and you should look elsewhere.
The trust question — what we can and can't confirm
Here's where we keep our enthusiasm measured. As of our latest check we could not find a visible LegitScript certification or PCAB-accredited compounding pharmacy badge on Freya's site, and the company doesn't name its compounding partner publicly. That's not evidence of a problem, but it's a missing signal we'd rather see, especially for a compounded-only service handling injectable medication. The large enrollment figure the company cites is self-reported and not something we can independently audit. To Freya's credit, there are no FDA warning letters on file against it, and the core service claims — the pricing, the unlimited consults, the free shipping — checked out against its live site. You can see how we weigh accreditation and transparency in our scoring methodology.
Who should choose Freya — and who should skip it
Freya makes the most sense if you specifically want a GLP-1-only provider, you value unlimited clinician access and a dietitian touchpoint, and you're comfortable committing to a quarterly or longer plan to bring the monthly cost down. The bundled support and single-category focus are the real selling points.
Skip it if you're price-shopping for the absolute lowest compounded rate — several competitors undercut it. Skip it too if you need brand-name medication, want to use insurance, prefer paying strictly month to month, or place a high priority on seeing published pharmacy accreditation before you hand over a card. Anyone who wants a true one-on-one coaching relationship rather than monthly group calls should also temper their expectations.
Bottom line
Freya Meds is a competent, narrowly focused GLP-1 program whose pricing rewards people who pay ahead and whose value lives in the bundled unlimited consults and dietitian access rather than in a low sticker price. It's above the market median, compounded-only, and short on visible accreditation, so it isn't our pick for bargain hunters or transparency sticklers. But for a patient who wants a dedicated GLP-1 service with real clinician support and is ready to commit to a multi-month plan, it's a reasonable option — just confirm the current plan terms and what the compounding pharmacy is before you enroll.
For a side-by-side, Direct Meds ($249/month) and bmiMD ($99/month) are the most comparable options to weigh against Freya Meds.
Ready to start with Freya Meds?
Starting at $250/month. See current pricing and start your free consultation.
Freya Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Freya Meds
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Freya Meds review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Freya Meds?
Starting at $250/month. See current pricing and start your free consultation.